Director

Prof. Dr. Dr. Ulrike Köhl (executive director)

Prof. Dr. Dr. Ulrike Köhl
© Fraunhofer IZI

Prof. Dr. Dr. Ulrike Köhl

Professional career

  • since 2017 W3-professorship for Immunoncology, Director of the Institute for Clinical Immunology at the University of Leipzig and University Hospital Leipzig
  • Director of the Fraunhofer Institute for Cell Therapy and Immunology Leipzig
  • Director (part time) of the Institute for Cell Therapeutics at the Hannover Medical School (MHH)
  • 2012–2017 W3- professorship and director of the Institute for Cell Therapeutics at the Hannover Medical School (MHH)
  • 1999–2012 Head of Laboratory for Stem Cell Transplantation and Immune Therapy, Department Pediatric Hematology, Oncology and Hemostaseology at the University Hospital Frankfurt (Main)
  • 2008–2010 Provisional management of the Emergency Laboratory for Hematology and coagulation, Department Pediatric Hematology, Oncology and Hemostaseology at the University Hospital Frankfurt (Main)
  • 1996–1998 Senior Scientist, Building the Laboratory for Stem Cell Transplantation, Department Pediatric Hematology and Oncology; Johann Wolfgang Goethe University Frankfurt and University Hospital Frankfurt (Main)
  • 1995–1996 Postdoctoral fellowship at the MD Anderson Cancer Center, Molecular Cell Therapy; Houston, USA
  • 1987–1995 Research Associate at the Pharmacokinetic Laboratory, Department Pediatric Hematology and Oncology; University Hospital Frankfurt (Main)

 

Education

  • 2008 - Habilitation und Venia Legendi for Experimental Medicine at Johann Wolfgang Goethe University Frankfurt
  • 2006 - Second state examination in Human Medicine at Johann Wolfgang Goethe University Frankfurt
  • 1995 - Doctorate in Pharmacology at Johann Wolfgang Goethe University Frankfurt
  • 1987 - Diploma in Biology at Johann Wolfgang Goethe University Frankfurt

 

Memberships (selection)

  • German Society for Hematology and Oncology (DGHO)
  • International Society for Cellular Therapy (ISCT)
  • German Society for Immunology (DGfI)
  • Paediatric Working Group for Bone Marrow and Blood Stem Cell Transplantation
  • Society of Paediatric Oncology and Haematology (GPOH)

Prof. Dr. Hans-Ulrich Demuth

Prof. Dr. Hans-Ulrich Demuth
© Fraunhofer IZI

Prof. Dr. Hans-Ulrich Demuth

Professional career

  • since 2015 Member of the directorate of Fraunhofer IZI, Head of the Branch Potsdam-Golm
  • since 2013 Head of the Department of Drug Design & Target Validation (Halle/Saale) of the Fraunhofer IZI
  • since 2013 Scientific Advisor of Probiodrug AG
  • 2007–2012 CEO of Ingenium GmbH, Martinsried
  • since 2006 Professor of Pharmabiotechnology, Anhalt University of Applied Sciences
  • 2001–2013 Co-Founder and Director R & D probiodrug research AG
  • 1996–2002 Lecturer of Enzymology, Friedrich-Schiller-University Jena
  • 1994 Heading Departement Drug Biochemistry at Hans Knöll Institute (Leibniz Institute for Natural Product Research and Infection Biology), Jena
  • 1990 Habilitation und venia legendi in Biochemistry
  • 1989 Postdoctoral fellowship at the Department of Pharmaceutical Pharmacology, Biomedical Research Center, University of Uppsala, Sweden
  • 1988 Assistant Professor at the Department of Biotechnology
  • 1989–1986 Postdoctoral fellowship at the Department of Chemistry, University of Kansas, USA
  • 1981–1987 Assistant Professor Department of Biochemistry

 

Education

  • 1977–1981 - Graduate studies in Biochemistry
  • 1973–1978 - Undergraduate in Biochemistry at Martin-Luther-University Halle (Saale)

 

Memberships (selection)

  • German Society of Biological Chemistry and Molecular Biology (GBM)
  • Protein Society (PS)
  • International Proteolysis Society (IPS)
  • American Diabetes Association (ADA)
  • American Chemical Society (ACS)
  • German Society of Mass Spectrometry (DGMS)
  • European Society for Advances to Study Diabetes (EASD)
  • New York Academy of Sciences
  • Society for Neurosciences (SfN)
  • Alzheimer’s Association (ISTAART)